Shanghai OPM Biosciences (SH:688293) Sou Hu Cai Jing·2025-08-25 13:56Core Insights - The stock price of Aopumai (688293) closed at 58.27 CNY on August 25, 2025, reflecting a 4.93% increase with a turnover rate of 3.59% and a trading volume of 27,800 lots, amounting to 162 million CNY in transaction value [1] Financial Performance - For the first half of 2025, Aopumai reported total revenue of 178 million CNY, representing a year-on-year growth of 23.77% - The net profit attributable to shareholders was 37.55 million CNY, showing a year-on-year increase of 55.55% - The non-recurring net profit was 29.58 million CNY, with a year-on-year growth of 76.73% - The company has a current ratio of 14.464, a quick ratio of 13.821, and a debt-to-asset ratio of 8.23% [1] Company Overview - Aopumai Biotechnology Co., Ltd. was established in 2013 and is located in Shanghai, focusing on research and experimental development - The company has a registered capital of 1,135.49 million CNY and a paid-in capital of 60 million CNY - The legal representative of the company is Xiao Zhihua [1][2] Investment and Intellectual Property - Aopumai has made investments in 8 companies and participated in 35 bidding projects - The company holds 71 trademark registrations and 104 patent applications, along with 65 administrative licenses [2]